Jun 25, 2025 08:02AM

Jun 25, 2025 08:00AM

Aug 6, 2024 04:01PM

Apr 8, 2022 08:00AM

Mar 15, 2022 08:00AM

Mar 4, 2022 08:00AM

Feb 8, 2022 08:03AM Ovid Therapeutics (OVID) Enters Strategic Partnership with Healx

Feb 8, 2022 08:00AM

Jan 3, 2022 06:40AM

Jan 3, 2022 06:30AM

Nov 10, 2021 08:30AM

Jun 4, 2021 08:01AM

Jun 4, 2021 08:00AM

May 26, 2021 08:19AM Ovid Therapeutics (OVID) Appoints Dr. Joy A. Cavagnaro and Dr. Bruce A. Sullenger to its Scientific Advisory Board

May 26, 2021 08:00AM

May 13, 2021 04:05PM

May 12, 2021 08:00AM

Apr 20, 2021 08:00AM

Apr 19, 2021 08:21AM

Apr 19, 2021 08:00AM

Mar 30, 2021 08:00AM Ovid Therapeutics Announces Closing of Agreement with Takeda for Global Development and Commercialization of Soticlestat

Mar 15, 2021 08:00AM

Mar 3, 2021 07:05AM

Mar 3, 2021 07:00AM

Dec 2, 2020 09:28AM

Aug 25, 2020 07:14AM

Aug 25, 2020 07:04AM

Aug 25, 2020 07:00AM Phase 2 ELEKTRA Study of Soticlestat (TAK-935/OV935) Meets Primary Endpoint Reducing Seizure Frequency in Children with Dravet Syndrome or Lennox-Gastaut Syndrome

Aug 25, 2020 07:00AM

Aug 6, 2018 09:27AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All